학술논문

Suvemcitug as second-line treatment of advanced or metastatic solid tumors and with FOLFIRI for pretreated metastatic colorectal cancer: phase Ia/Ib open label, dose-escalation trials
Document Type
Article
Source
In ESMO Open June 2023 8(3)
Subject
Language
ISSN
2059-7029